Pyrimidine derivative
AssigneeAska Pharmaceutical Co., Ltd.
InventorsMakoto OKADA, Youichi NAKANO, Takashi NOSE, Satoshi MAEDA, Tomoaki WATANABE
Life of this patent
Estimating the term…
Abstract
A compound of the formula (I) or a salt thereof (R represents methyl group or fluorine atom) having an mPGES-1 inhibitory activity and useful as an active ingredient of a medicament for prophylactic and/or therapeutic treatment of such diseases as inflammation, pain, or rheumatism.
Claims2
A method for preventing and/or treating inflammation, pain, rheumatism, osteoarthritis, pyrexia, Alzheimer's disease, multiple sclerosis, arteriosclerosis, ocular hypertension, ischemic retinopathy systemic scleroderma, malignant tumor, overactive bladder, bladder outlet obstruction associated with benign prostatic hyperplasia, nocturia, urinary incontinence, neurogenic bladder, interstitial cystitis, bladder pain syndrome, urinary calculus, benign prostatic hyperplasia, or a disease for which suppression of the PGE2 production exhibits efficacy which comprises administrating an effective amount of a compound represented by the following general formula (I):
- in the formula, R represents methyl group or fluorine atom, or a physiologically acceptable salt thereof to a mammal including human.
Dependencies are inferred from the claim text.